New 4‐phenylpiperazine‐carbodithioate‐<i>N</i>‐phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α‐glucosidase enzymes
Maryam Mohammadi‐Khanaposhtani(Babol University of Medical Sciences), Parham Taslımı(Bartin University), Mahmood Biglar(Tehran University of Medical Sciences), Hamdi KAMÇI(Bartin University), Ali Moaazam(Tehran University of Medical Sciences), Yousef Valizadeh(Tehran University of Medical Sciences), Navid Dastyafteh(Iran University of Science and Technology), Ahmet KARAKUŞ(Bartin University), Shahrzad Javanshir(Iran University of Science and Technology), Samanesadat Hosseini(Shahid Beheshti University of Medical Sciences), Hossein Adibi(Tehran University of Medical Sciences), Milad Nori(Tehran University of Medical Sciences), Bagher Larijani(Tehran University of Medical Sciences), Mohammad Mahdavi(Shaheed Rajaei Cardiovascular Medical and Research Center), Haleh Hamedifar(Biotechnology Research Center)
Cited by 16
Related Papers
The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report
|The Lancet|2019|3k
Antidiabetic and antiparasitic potentials: Inhibition effects of some natural antioxidant compounds on α-glycosidase, α-amylase and human glutathione S-transferase enzymes
|International Journal of Biological Macromolecules|2018|215
Synthesis, biological evaluation and molecular docking of novel pyrazole derivatives as potent carbonic anhydrase and acetylcholinesterase inhibitors
|Bioorganic Chemistry|2019|202
Gut microbiota-derived metabolites in obesity: a systematic review
|Bioscience of Microbiota Food and Health|2020|178
The challenge for global health systems in preventing and managing obesity
|Obesity Reviews|2019|128